Optometry in 2024: What to Expect for the New Year
WEBDecember 21, 2023. If optometry in 2024 is anything like what we’ve witnessed in 2023, it could prove to be a year filled with innovative therapies for dry eye disease (DED), legislative victories, and new ways of comanaging geographic atrophy (GA). While optometrists have many reasons to celebrate, some events may cloud what has, for the ...
Multifocals for Myopia Management – More Than Meets the Eye
WEBDec 10, 2021 · Low dose atropine drops, orthokeratology and multifocal contact lenses have all demonstrated success with reducing the rate of myopia progression and in reducing the axial length of the eye. 1-3 Recently, a lens with a multifocal lens design has been approved for the management of myopia progression, the …
Lens-Based Myopia Control: Know When to Treat and Expect Results
WEBDec 15, 2023 · Treatments were decided based on the results of this data analysis and patients were monitored every 3 to 6 months for progression, which was defined as 0.25 D or greater myopia spherical equivalent progression (as assessed with cycloplegic autorefraction) or greater than 0.10 mm axial elongation in 6 months. Children who showed progression while on one treatment, received a change in treatment.
Optometry Advisor Redesign: New Look, Same Vision
WEBBill Kekevian is the senior editor of Ophthalmology Advisor and Optometry Advisor. He has served as a writer and editor covering ophthalmology and optometry since 2012. He can be reached at [email protected]. Stephen J. Bohacik. Stephen J. Bohacik is an editor with Haymarket Media and a multi-year veteran of the eye care profession.
Technological Updates Enhance the Optometric Exam Experience
WEBAug 4, 2023 · Credit: Getty Images Miriam Korik, OD, explains the importance of keeping abreast of technological advancements and implementing them in the office to improve patients’ eye care experience.
Red Light Therapy Provides Myopia Control ... - Optometry Advisor
WEBNovember 22, 2023. As optometrists struggle with the demand created by an emerging myopia epidemic, repeated low-level red light therapy may provide an alternative to contact lens wear or atropine treatment for slowing axial progression and spherical equivalent refraction (SER). While the treatment has yet to receive US Food and Drug ...
2022: A Year of Triumphs and Breakthroughs in Optometry
WEBDec 22, 2022 · Optometry Advisor looks back at some of the top stories of 2022. In 2022, optometrists saw legislative victories in Virginia — where optometrists can now perform YAG laser capsulotomies, selective laser trabeculoplasties, and laser peripheral iridotomies — and Colorado — where ODs can now perform those …
FDA Alert: Optometry Drug and Device Updates
WEBJanuary 18, 2024. In the last few weeks, The US Food and Drug Administration (FDA) has approved loteprednol etabonate ophthalmic suspension, 0.2% (Lupin), a generic version of the drug Prolensa ® (Bausch + Lomb), for treating seasonal allergies. 1 The agency has also provided feedback to medical device manufacturer LumiThera, Inc., resulting ...
Extended Anti-VEGF Treatment Intervals Improve Best VA in DME ...
WEBApr 10, 2024 · Extended anti-vascular endothelial growth factor (VEGF) treatment intervals (between 8 and 12 weeks) may produce better best visual acuity (BVA) outcomes among individuals with diabetic macular edema (DME) compared with those obtained with treatment intervals of 8 weeks or less, according to a study published in Eye.. Investigators included 291 patients (mean age, 63.8 years; 51.2% women) with ...
A Clinician's Guide to Peripheral Iridotomy - Optometry Advisor
WEBDec 2, 2022 · Several states have recently enacted legislation which expands optometry’s scope of practice — many of them involving laser procedures. Jeff M. Miller, OD, of the Northeastern State University Oklahoma School of Optometry details the process of performing the laser peripheral iridotomy procedure and discusses pre, peri, and postoperative considerations.
Skip to content